Humacyte, Inc. (HUMAW) NASDAQ
0.08
-0.0111(-12.60%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.08
-0.0111(-12.60%)
Currency In USD
| Market Cap | 151.91M |
| Enterprise Value | 166.26M |
| P/E Ratio | -2.75 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 54.7 |
| Price/Book Ratio | 36.17 |
| Enterprise/Revenue | 61.74 |
| Enterprise/EBITDA | -1.26 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -20.04 |
| Operating Margin | -53.06 |
| Return On Assets | -0.35 |
| Return On Equity | -4.25 |
| Revenue | 2.04M |
| Revenue/Share | 0.01 |
| Gross Profit | -15.01M |
| EBITDA | -100.09M |
| Net Income | -40.83M |
| Diluted EPS | -0.26 |
| Total Cash | 50.5M |
| Total Cash/Share | 0.32 |
| Total Debt | 64.85M |
| Total Debt/Equity | 20.86 |
| Current Ratio | 3.69 |
| Book Value Per Share | 0.02 |
| 52-Week Change | -81.22 |
| 52-Week High | 0.23 |
| 52-Week Low | 0.08 |
| Moving Average 50 Days | 0.1 |
| Moving Average 200 Days | 0.21 |
| Average Volume | 19,110.17 |
| Shares Outstanding | 1.2B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |